(Q54367568)

28 May 2018

title

High-level production of a single chain antibody against anthrax toxin in Escherichia coli by high cell density cultivation. (English)

1 reference

28 May 2018

1 reference

Ki Jun Jeong

1

1 reference

28 May 2018

Mridula Rani

series ordinal

2

1 reference

28 May 2018

publication date

25 February 2011

1 reference

28 May 2018

Bioprocess and Biosystems Engineering

published in

1 reference

28 May 2018

volume

34

1 reference

28 May 2018

issue

7

1 reference

28 May 2018

page(s)

811-817

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1007/s00449-011-0531-1

exact match

0 references

cites work

Engineered antibody fragments and the rise of single domains

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Isolation and expression of recombinant antibody fragments to the biological warfare pathogen Brucella melitensis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Escherichia coli skp chaperone coexpression improves solubility and phage display of single-chain antibody fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Certolizumab pegol for the management of Crohn's disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

High cell-density culture of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Growing E. coli to high cell density--a historical perspective on method development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

High level Escherichia coli expression and production of a bivalent humanized antibody fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

A plasmid system for optimization of Fab' production in Escherichia coli: importance of balance of heavy chain and light chain synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Identification of framework residues in a secreted recombinant antibody fragment that control production level and localization in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Broad-host-range plasmid pJB658 can be used for industrial-level production of a secreted host-toxic single-chain antibody fragment in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Proteomic profiling of recombinant Escherichia coli in high-cell-density fermentations for improved production of an antibody fragment biopharmaceutical

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Functional expression and display of an antibody Fab fragment in Escherichia coli: study of vector designs and culture conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Constitutive production of human leptin by fed-batch culture of recombinant rpoS- Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Protein PEGylation decreases observed target association rates via a dual blocking mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Tailoring structure-function and pharmacokinetic properties of single-chain Fv proteins by site-specific PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

Evolution of highly active enzymes by homology-independent recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00449-011-0531-1

10.1007/S00449-011-0531-1

21 January 2018

Identifiers

DOI

1 reference

28 May 2018

PubMed ID

21350955

1 reference

28 May 2018